🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary: To characterize the safety of RIXUBIS when used under normal clini...
Status
Completed
Location
Daegu Catholic University Medical Center
Start Date
2017-01-06
Trial ID
NCT02922231
Treatments Being Tested
The purpose of this pivotal Phase 1/3 study is to determine the pharmacokin...
Status
Completed
Location
Multiple Locations
Start Date
2010-07-29
Trial ID
NCT01174446
The purpose of the study is to assess the hemostatic efficacy and safety of...
Status
Completed
Location
Instituto de Hematología y Medicina Clínica Rubén Dávoli
Start Date
2011-12-19
Trial ID
NCT01507896
Treatments Being Tested
The purpose of this BAX 326 Continuation Study is to further investigate in...
Status
Completed
Location
Instituto de Hematología y Medicina Clíncia Rubén Dávoli
Start Date
2011-04-12
Trial ID
NCT01286779
Treatments Being Tested
The purpose of this study is to characterize the safety and describe the ef...
Status
Completed
Location
Sahyadri Super Speciality Hospital
Start Date
2018-12-07
Trial ID
NCT03565237
Treatments Being Tested
The purpose of this survey is to understand the following items observed in...
Status
Completed
Location
Seki-shi, Japan
Start Date
2016-11-16
Trial ID
NCT02937831
Treatments Being Tested
The purpose of this study is to assess BAX 326 pharmacokinetic parameters, ...
Status
Completed
Location
LNJP Maulana Azad Medical College & Associated Hospitals
Start Date
2011-12-20
Trial ID
NCT01488994
Treatments Being Tested
The primary objective of this study is to prospectively document the exposu...
Status
Completed
Location
Hospital JR Vidal (Servicio de Hemotologie - Area de Investiagacion
Start Date
2010-05-31
Trial ID
NCT01128881
Treatments Being Tested